Original fundamental research starts and ENDS here.
Sectors Tags Blog
CVX
2 filings
Timeline Columns Start Research 8-K Categories
Showing: Shareholder Meeting Clear filter
2025
Q2 1 filings
May
2025 Annual Shareholder Meeting
Officer exculpation amendment approved with 62.5% of outstanding shares
8-K
2024
Q2 1 filings
May
Annual Shareholder Meeting Results
All 12 directors elected, 4 shareholder proposals rejected
8-K
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.